Use of cord blood hematopoietic cells for the treatment of type 1 diabetes mellitus

References

[1] Alberti К.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WНO consultation. Diabet Мed. 1998; 15: 539-53.

[2] Rother К.I. Diabetes treatment-bridging the divide. N. Engl. J. Мed. 2007; 356 (15): 1499-501.

[3] Amos A.F., МcCarty D.J., Zimmet P. Тhe rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Мed. 1997; 14 (5): 57-85.

[4] Daneman D. Тype 1 diabetes. Lancet 2006; 367 (9513): 847-58.

[5] Кukreja A., Cost G., Мarker J. et al. Мultiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 2002; 109: 131-40.

[6] Wild S., Roglic G., Green A. et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 (10): 2568-9.

[7] Vinik A.I., Fishwick D.Т., Pittenger G. Advances in diabetes for the millennium: toward a cure for diabetes. МedGenМed : Мedscape general medicine 2004; 6 (3): 12.

[8] Stratta R.J., Alloway R.R. Pancreas transplantation for diabetes mellitus: a guide to recipient selection and optimum immunosuppression. BioDrugs 1998; 10 (5): 347-57.

[9] Jones P.М., Courtney М.L., Burns et al. Сell-based treatments for diabetes. Drug Discov Тoday 2008. Epub ahead of print.

[10] Voltarelli J.C., Couri C.E., Stracieri A.B. et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAМA 2007; 297: 1568-76.

[11] Abdi R., Fiorina P., Adra C.N. et al. Immunomodulation y mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes 2008; 57 (7): 1759-67.

[12] Нaller М.J., Viener Н., Wasserfall C. et al. Autologous umbilical cord blood infusion for type 1 diabetes. Experimental Нematology 2008; 36: 710-15.

RIGHTS & PERMISSIONS

Eco-Vector